Regent Pacific FY26 H1 returns to profit of US$544,000; revenue rises to US$5.28 million

By Public Technologies
  • Regent Pacific swung to a profit of US$544,000 from a loss of US$2.22 million a year earlier.
  • Revenue more than doubled to US$5.28 million, while operating profit turned to US$2.38 million from an operating loss of US$2.01 million.
  • Trade receivables jumped 6,263% to US$5.22 million, mainly due to a US$5 million Senstend milestone receivable from Fosun Wanbang.
  • NMPA approved Senstend in China on June 10, triggering the US$5 million milestone; another US$2 million is payable on first China sale.
  • Deep Longevity posted US$69,000 in revenue and targets a US consumer digital telehealth launch in the final quarter of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260921-12339287), on September 21, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.